サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1411795

エイコサペンタエン酸市場：供給源別、用途別-2024～2030年の世界予測

Eicosapentaenoic Acid Market by Source (Algae, Fish, Krill), Application (Dietary Supplements, Functional Food & Beverages, Pharmaceuticals) - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 194 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
エイコサペンタエン酸市場：供給源別、用途別-2024～2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

エイコサペンタエン酸市場規模は2023年に8億5,468万米ドルと推定され、2024年には9億149万米ドルに達すると予測され、CAGR 4.55%で2030年には11億6,725万米ドルに達すると予測されます。

エイコサペンタエン酸の世界市場

主要市場の統計
基準年[2023年] 8億5,468万米ドル
予測年[2024年] 9億149万米ドル
予測年[2030年] 11億6,725万米ドル
CAGR（%） 4.55%
エイコサペンタエン酸 Market-IMG1

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスはエイコサペンタエン酸市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます。フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、エイコサペンタエン酸市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発とイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-エイコサペンタエン酸市場の市場規模と予測は？

2-エイコサペンタエン酸市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-エイコサペンタエン酸市場における技術動向と規制の枠組みは？

4-エイコサペンタエン酸市場における主要ベンダーの市場シェアは？

5-エイコサペンタエン酸市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性疾患の有病率上昇のリスクを低下させるためのエイコサペンタエン酸の重要性
      • エイコサペンタエン酸の摂取に対する国民の健康意識の高まり
      • 栄養食品と幼児用食品への支出の増加
    • 抑制要因
      • エイコサペンタエン酸に必要な原材料の入手可能性に関連する問題
    • 機会
      • 持続可能なビーガンエイコサペンタエン酸の採用
      • エイコサペンタエン酸のサービスを拡大するための投資の増加
    • 課題
      • エイコサペンタエン酸の摂取に伴う副作用の可能性
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 エイコサペンタエン酸市場：供給源別

  • イントロダクション
  • 藻類
  • 魚類
  • オキアミ

第7章 エイコサペンタエン酸市場：用途別

  • イントロダクション
  • 栄養補助食品
  • 機能性食品と飲料
  • 医薬品

第8章 南北アメリカのエイコサペンタエン酸市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋のエイコサペンタエン酸市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのエイコサペンタエン酸市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第12章 競合ポートフォリオ

  • 主要な企業プロファイル
    • AlgiSys BioSciences Inc
    • Archer Daniels Midland Company
    • Arctic Nutrition AG
    • Asterisk Laboratories（I）Pvt. Ltd.
    • BASF SE
    • BIOSEARCH, SA
    • Cayman Chemical Company
    • Corbion N.V.
    • Croda International PLC
    • Epax Norway AS
    • Evonik Industries AG
    • Golden Omega S.A.
    • Indo Rama Engineers
    • KD Pharma Group
    • Koninklijke DSM N.V.
    • Novasep Holding SAS
    • Novotech Nutraceuticals, Inc.
    • Omega Protein Corporation
    • Orkla Health AS
    • Pelagia AS
    • Santa Cruz Biotechnology, Inc.
    • Shandong Yuwang Pharmaceutical Co., Ltd.
    • SimSon Pharma Limited
    • Sinomega Biotech Engineering Co.,Ltd
    • Toronto Research Chemicals Inc
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. EICOSAPENTAENOIC ACID MARKET RESEARCH PROCESS
  • FIGURE 2. EICOSAPENTAENOIC ACID MARKET SIZE, 2023 VS 2030
  • FIGURE 3. EICOSAPENTAENOIC ACID MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. EICOSAPENTAENOIC ACID MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. EICOSAPENTAENOIC ACID MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. EICOSAPENTAENOIC ACID MARKET DYNAMICS
  • FIGURE 7. EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 8. EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS EICOSAPENTAENOIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS EICOSAPENTAENOIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES EICOSAPENTAENOIC ACID MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES EICOSAPENTAENOIC ACID MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC EICOSAPENTAENOIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC EICOSAPENTAENOIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA EICOSAPENTAENOIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA EICOSAPENTAENOIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EICOSAPENTAENOIC ACID MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. EICOSAPENTAENOIC ACID MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. EICOSAPENTAENOIC ACID MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. EICOSAPENTAENOIC ACID MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EICOSAPENTAENOIC ACID MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 6. EICOSAPENTAENOIC ACID MARKET SIZE, BY ALGAE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. EICOSAPENTAENOIC ACID MARKET SIZE, BY FISH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. EICOSAPENTAENOIC ACID MARKET SIZE, BY KRILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 10. EICOSAPENTAENOIC ACID MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. EICOSAPENTAENOIC ACID MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. EICOSAPENTAENOIC ACID MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS EICOSAPENTAENOIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES EICOSAPENTAENOIC ACID MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC EICOSAPENTAENOIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA EICOSAPENTAENOIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM EICOSAPENTAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM EICOSAPENTAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. EICOSAPENTAENOIC ACID MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 100. EICOSAPENTAENOIC ACID MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. EICOSAPENTAENOIC ACID MARKET LICENSE & PRICING
目次
Product Code: MRR-C002B1C9970B

[194 Pages Report] The Eicosapentaenoic Acid Market size was estimated at USD 854.68 million in 2023 and expected to reach USD 901.49 million in 2024, at a CAGR 4.55% to reach USD 1,167.25 million by 2030.

Global Eicosapentaenoic Acid Market

KEY MARKET STATISTICS
Base Year [2023] USD 854.68 million
Estimated Year [2024] USD 901.49 million
Forecast Year [2030] USD 1,167.25 million
CAGR (%) 4.55%
Eicosapentaenoic Acid Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Eicosapentaenoic Acid Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Eicosapentaenoic Acid Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Eicosapentaenoic Acid Market, highlighting leading vendors and their innovative profiles. These include AlgiSys BioSciences Inc, Archer Daniels Midland Company, Arctic Nutrition AG, Asterisk Laboratories (I) Pvt. Ltd., BASF SE, BIOSEARCH, SA, Cayman Chemical Company, Corbion N.V., Croda International PLC, Epax Norway AS, Evonik Industries AG, Golden Omega S.A., Indo Rama Engineers, KD Pharma Group, Koninklijke DSM N.V., Novasep Holding SAS, Novotech Nutraceuticals, Inc., Omega Protein Corporation, Orkla Health AS, Pelagia AS, Santa Cruz Biotechnology, Inc., Shandong Yuwang Pharmaceutical Co., Ltd., SimSon Pharma Limited, Sinomega Biotech Engineering Co.,Ltd, and Toronto Research Chemicals Inc.

Market Segmentation & Coverage

This research report categorizes the Eicosapentaenoic Acid Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Source
    • Algae
    • Fish
    • Krill
  • Application
    • Dietary Supplements
    • Functional Food & Beverages
    • Pharmaceuticals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Eicosapentaenoic Acid Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Eicosapentaenoic Acid Market?

3. What are the technology trends and regulatory frameworks in the Eicosapentaenoic Acid Market?

4. What is the market share of the leading vendors in the Eicosapentaenoic Acid Market?

5. Which modes and strategic moves are suitable for entering the Eicosapentaenoic Acid Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Eicosapentaenoic Acid Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significance of EPA for lowering risk of rising prevalence of chronic diseases
      • 5.1.1.2. Rising health awareness of consumption eicosapentaenoic acids among population
      • 5.1.1.3. Rise in spending on nutritional and infant food products
    • 5.1.2. Restraints
      • 5.1.2.1. Issues associated with availability of raw materials required for EPA
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of sustainable and vegan EPA
      • 5.1.3.2. Rising investments to expand EPA offerings
    • 5.1.4. Challenges
      • 5.1.4.1. Possibilities of side effects associated with consumption of EPA
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Eicosapentaenoic Acid Market, by Source

  • 6.1. Introduction
  • 6.2. Algae
  • 6.3. Fish
  • 6.4. Krill

7. Eicosapentaenoic Acid Market, by Application

  • 7.1. Introduction
  • 7.2. Dietary Supplements
  • 7.3. Functional Food & Beverages
  • 7.4. Pharmaceuticals

8. Americas Eicosapentaenoic Acid Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Eicosapentaenoic Acid Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Eicosapentaenoic Acid Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. AlgiSys BioSciences Inc
    • 12.1.2. Archer Daniels Midland Company
    • 12.1.3. Arctic Nutrition AG
    • 12.1.4. Asterisk Laboratories (I) Pvt. Ltd.
    • 12.1.5. BASF SE
    • 12.1.6. BIOSEARCH, SA
    • 12.1.7. Cayman Chemical Company
    • 12.1.8. Corbion N.V.
    • 12.1.9. Croda International PLC
    • 12.1.10. Epax Norway AS
    • 12.1.11. Evonik Industries AG
    • 12.1.12. Golden Omega S.A.
    • 12.1.13. Indo Rama Engineers
    • 12.1.14. KD Pharma Group
    • 12.1.15. Koninklijke DSM N.V.
    • 12.1.16. Novasep Holding SAS
    • 12.1.17. Novotech Nutraceuticals, Inc.
    • 12.1.18. Omega Protein Corporation
    • 12.1.19. Orkla Health AS
    • 12.1.20. Pelagia AS
    • 12.1.21. Santa Cruz Biotechnology, Inc.
    • 12.1.22. Shandong Yuwang Pharmaceutical Co., Ltd.
    • 12.1.23. SimSon Pharma Limited
    • 12.1.24. Sinomega Biotech Engineering Co.,Ltd
    • 12.1.25. Toronto Research Chemicals Inc
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing